ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
22 Jan 2020 11:14

How Will Mr. Market View 30% Cap Rule for Samsung Electronics & KOSPI200?

Instead of the bi-annual adjustment, the Korea Exchange is considering on changing the 30% cap rule so that the timing of the adjustment is...

Logo
608 Views
Share
22 Jan 2020 07:54

KRX Considers a 30% Cap on Samsung in March: Impact Estimation

The local news outlets report that the KRX is considering applying the 30% cap on Samsung Electronics as early as March, possibly right after the...

Logo
656 Views
Share
21 Jan 2020 17:51

Korea - Celltrion Shorts Increase, Semco Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 17 January 2020....

Logo
506 Views
Share
bullishCelltrion Inc
16 Jan 2020 14:25

Celltrion Merger: Is It for Real This Time? Why Next Year?

Almost every year, we hear this same old story about the Celltrion merger when we approach the OGM season in March. It has always been Chairman Seo...

Logo
599 Views
Share
16 Jan 2020 11:24

A Potential Merger of Celltrion, Celltrion Healthcare, & Celltrion Pharma?

The Celltrion Group Chairman Seo Jung-Jin made an important announcement at a JP Morgan Conference in San Francisco on January 15th. Chairman Seo...

Logo
680 Views
Share
x